Sofwave Muscle Stimulation Device Improves Strength and Endurance in Clinical Study
A randomized controlled study of Sofwave's FDA-cleared Pure Impact VIP platform found functional gains, with most improvements sustained four weeks after treatment.
Useful takeaways from this story.
A randomized controlled study of Sofwave's FDA-cleared Pure Impact VIP platform found functional gains, with most improvements sustained four weeks after treatment.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
A randomized controlled study of Sofwave's FDA-cleared Pure Impact VIP platform found functional gains, with most improvements sustained four weeks after treatment.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.